A patent review of apelin receptor (APJR) modulators (2014-2019)
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Therapeutic Patents"
DOI: 10.1080/13543776.2020.1731473
Abstract: ABSTRACT Introduction: The apelinergic system is regarded as a novel therapeutic target for cardiovascular health, fluid homeostasis, the hypothalamic-pituitary-adrenal (HPA) axis as well as carbohydrate and fat metabolism. Two endogenous peptide ligands, namely apelin and… read more here.
Keywords: patent review; small molecule; 2014 2019; apjr ... See more keywords